Actively Recruiting
Rectus Sheath Block in Cardiac Surgery
Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-09-23
75
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of a type of peripheral nerve block, Rectus Sheath Block. 1. Does the rectus sheath block decrease opioid consumption postoperatively after cardiac surgery? 2. Does the rectus sheath block decrease VAS pain scores postoperatively after cardiac surgery? Study participants will be assigned to receive either rectus sheath block or no block.
CONDITIONS
Official Title
Rectus Sheath Block in Cardiac Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 to 85 years old
- Scheduled to undergo cardiac procedures involving chest tubes
- Male or female
You will not qualify if you...
- ASA class V
- Urgent or emergent surgery
- Contraindications to local anesthesia such as allergy to local anesthetics
- History of substance abuse or chronic opioid use
- Patient refusal or inability to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mount Sinai Morningside Hospital Center
New York, New York, United States, 10023
Actively Recruiting
Research Team
A
Ali Shariat, MD
CONTACT
H
Himani Bhatt, DO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here